Clinical Trials Directory

Trials / Completed

CompletedNCT04338893

ROSA Total Knee Post Market Study EMEA

ROSA Total Knee Post Market Study: a Prospective, Multicenter EMEA Post Market Clinical Follow up of the ROSA Knee System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
252 (actual)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, multicenter clinical study designed to facilitate the collection and evaluation of surgical workflow efficiency, patient pain and function outcome and adverse events data. This study might include Persona, Nexgen and Vanguard product families using the ROSA Total Knee Robotic system or conventional instrumentation. The primary objective is to evaluate the accuracy of implant alignment for ROSA Total Knee robotic instrumentation compared to conventional instrumentation.

Detailed description

The main purpose of this study is to collect and compare clinical outcomes data using the commercially available ROSA Total Knee robotic instrumentation and conventional instrumentation. This will be achieved by assessing: planned vs actual component positioning, operative workflow efficiency, patient safety based on incidence and frequency of adverse events, clinical performance measured by overall pain and function, health-related quality of life data and radiographic parameters. The primary endpoint will report on the accuracy of implant alignment for ROSA Total Knee robotic instrumentation compared to conventional and the secondary endpoints will record surgery time points and evaluate the change of clinical outcomes scores between baseline and post operative follow up for performance and clinical benefits

Conditions

Interventions

TypeNameDescription
PROCEDUREDevice: Persona Total KneeThe choice of intervention is defined by surgeons standard use of device 'Persona' in their standard of care practice
PROCEDUREDevice: NexGen Total KneeThe choice of intervention is defined by surgeons standard use of device 'Nexgen' in their standard of care practice
PROCEDUREDevice: Vanguard Total KneeThe choice of intervention is defined by surgeons standard use of device 'Vanguard' in their standard of care practice

Timeline

Start date
2020-12-15
Primary completion
2025-08-22
Completion
2025-08-22
First posted
2020-04-08
Last updated
2026-01-21
Results posted
2026-01-21

Locations

6 sites across 5 countries: Belgium, Germany, Israel, Italy, Switzerland

Source: ClinicalTrials.gov record NCT04338893. Inclusion in this directory is not an endorsement.

ROSA Total Knee Post Market Study EMEA (NCT04338893) · Clinical Trials Directory